New study: simple MRI and blood test may predict cancer spread
NCT ID NCT05950594
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a special MRI scan and blood tests can predict if soft-tissue sarcoma will spread to other parts of the body. Researchers will look at markers of low oxygen levels in the tumor and blood. The goal is to help doctors personalize treatment for each patient. About 145 adults with high-risk sarcoma will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Health Network
RECRUITINGToronto, Ontario, L4W4C2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive antibody light up hidden tumors?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a targeted pill stall advanced sarcomas?
- Protein-Wrapped chemo aims to hit tumors harder, spare healthy cells
- Drug duo takes on rare head and neck tumors